0000899243-16-013573.txt : 20160217 0000899243-16-013573.hdr.sgml : 20160217 20160217174813 ACCESSION NUMBER: 0000899243-16-013573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160214 FILED AS OF DATE: 20160217 DATE AS OF CHANGE: 20160217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Studer Jacqueline CENTRAL INDEX KEY: 0001526223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 161435289 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001526223 Studer Jacqueline ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 See Remarks Common Stock 2016-02-14 4 M 0 346 0.00 A 1338 D Common Stock 2016-02-14 4 F 0 130 67.85 D 1208 D Non-Qualified Stock Option (right-to-buy) 67.85 2016-02-14 4 A 0 22027 A 2026-02-13 Common Stock 22027 22027 D Incentive Stock Option (right-to-buy) 67.85 2016-02-14 4 A 0 1477 A 2026-02-13 Common Stock 1477 1477 D Restricted Stock Unit 2016-02-14 4 A 0 2027 A Common Stock 2027 8271 D Restricted Stock Unit 2016-02-14 4 M 0 346 D Common Stock 346 7925 D Includes 145 shares in total acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2015 (66) and December 31, 2015 (79), respectively. Closing price of Issuer's common stock on the NASDAQ market on February 12, 2016. Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). Not applicable. Corporate VP, General Counsel and Secretary /s/ Jacqueline L. Studer 2016-02-17